Nigeria Begins Local Packaging of WHO-Approved HIV Test in Lagos Facility

Nigeria Begins Local Packaging of WHO-Approved HIV Test in Lagos Facility

News Media Nigeria

Nigeria Begins Local Packaging of WHO-Approved HIV Test in Lagos Facility

 

Advertisement
Ad imageAd image

 

Advertisement
nlngnlng

By Chidinma Onwumere

 

Advertisement
Ad imageAd image

Nigeria has recorded a significant milestone in its quest for greater health system self-reliance with the local packaging of a World Health Organization (WHO) pre-qualified HIV Rapid Diagnostic Test (RDT) at a facility in Lagos.

The development follows regulatory approval under the WHO Pre-Qualification Change Notification process, authorising the local packaging of the Standard Q HIV 1 & 2 Rapid Diagnostic Test at Colexa Biosensor, a Nigerian-based facility. The site is currently the only facility in Africa approved to package a WHO-prequalified HIV rapid test kit.

Until now, the product had been manufactured and imported into Nigeria as a fully finished diagnostic commodity. The new approval allows the final packaging process to take place locally, while maintaining the same global quality standards attached to WHO pre-qualification.

Strengthening Supply Chain Resilience

WHO pre-qualification is an internationally recognised quality benchmark used by governments, donors, and procurement agencies to guide decisions on medical commodities for public health programmes. Any modification to a pre-qualified product — including a change in packaging location — must undergo strict assessment to ensure quality, safety, and performance remain unaffected.

Advertisement
Ad imageAd image

Public health experts say the approval represents more than a regulatory achievement. It addresses a long-standing vulnerability in many African health systems: heavy reliance on imported diagnostics and exposure to disruptions in global supply chains.

During the COVID-19 pandemic and other global shocks, delays in the delivery of essential health commodities highlighted the risks associated with overdependence on distant manufacturing hubs. By enabling local packaging of a WHO-approved HIV test, Nigeria can reduce lead times, respond more quickly to demand fluctuations, and improve continuity of supply for its national HIV response.

Backed by National Health Authorities

The test has been evaluated and approved by the Federal Ministry of Health and the National AIDS and STI Control Programme (NASCP). It is also listed on Nigeria’s National HIV Testing Algorithm — a critical requirement that determines which diagnostic kits can be used in public health facilities and donor-supported programmes.

Inclusion on the national algorithm ensures that testing tools meet defined performance standards and align with Nigeria’s HIV testing strategy. It also allows international partners and multilateral agencies supporting HIV services in the country to procure the product locally while remaining compliant with global quality requirements.

Economic and Institutional Impact

Beyond improving supply reliability, the move is expected to generate broader institutional and economic benefits. Local packaging can shorten supply chains, reduce logistics costs, and enhance predictability in procurement cycles.

It also creates opportunities for skills transfer in quality management, regulatory compliance, and manufacturing operations. However, experts emphasise that local involvement does not mean lowering standards. WHO approval for local packaging requires strict adherence to standardised procedures, comprehensive traceability systems, and continuous audit compliance.

Health policy analysts say the development challenges the assumption that high-quality diagnostic production must take place outside Africa. With appropriate regulatory oversight and technical partnerships, African facilities are increasingly demonstrating their capacity to meet globally recognised benchmarks.

Broader Health Implications

The Lagos facility’s operations extend beyond HIV diagnostics. It also produces blood glucose meters and test strips, reflecting a growing focus on non-communicable diseases such as diabetes — a rapidly rising public health concern in Nigeria and across the continent.

This dual focus on communicable and non-communicable diseases aligns with evolving healthcare priorities, as African countries contend simultaneously with infectious disease burdens and increasing rates of chronic illness.

A Model for Regional Replication

While the immediate impact of the approval is national, health sector stakeholders believe the regulatory pathway demonstrated in Nigeria could serve as a model for other African countries seeking to expand local production and packaging of essential medical commodities.

Regional health bodies have long advocated for increased local participation in the value chain of global health products, citing both health security and economic development goals. Progress, however, has often been slowed by regulatory complexity, stringent quality assurance requirements, and limited technical capacity.

By successfully meeting WHO pre-qualification standards for local packaging, Nigeria provides a practical example of how these barriers can be navigated through collaboration between global manufacturers, local operators, national regulators, and international agencies.

Toward Greater Health System Self-Reliance

As demand for HIV testing remains high — particularly among key populations and underserved communities — sustained access to reliable, quality-assured diagnostics remains central to prevention, treatment, and surveillance efforts.

Local packaging does not eliminate dependence on global supply chains, but it strengthens resilience, enhances responsiveness, and improves contextual adaptability.

More broadly, the initiative contributes to an ongoing continental conversation about moving from consumption to participation in global health manufacturing value chains. In that sense, the local packaging of a WHO-approved HIV test represents not merely a procedural regulatory change, but a gradual and meaningful shift toward health system self-reliance grounded in global standards.

As African governments and development partners intensify efforts around pandemic preparedness, universal health coverage, and supply chain resilience, such models are likely to play an increasingly important role in shaping the future of healthcare delivery across the continent.

Share This Article
Leave a Comment